BPC-157

BPC-157 is the most-discussed recovery peptide in circulation. Originally isolated from human gastric juice, it has shown broad tissue-healing effects in animal models — particularly for tendon-to-bone healing, gut barrier integrity, and vascular repair. Human data is limited, which is why it remains research-use-only in most regions, but anecdotal reporting is unusually consistent.

A pentadecapeptide fragment of a gastric protein. Promotes angiogenesis, upregulates growth factors, and stabilizes the gut barrier.

• Recovery

  Recovery & Tissue Repair

  Strongest signal in tendon/ligament/muscle repair.

  STRENGTH

  95%
• Gut

  Gut & Digestive Healing

  Repairs intestinal barrier, especially post-NSAID damage.

  STRENGTH

  92%
• Inflammation

  Inflammation Control

  Downregulates pro-inflammatory cytokines.

  STRENGTH

  75%

Well tolerated in available studies. Long-term human safety data is limited.

• Active malignancy (theoretical, due to angiogenic action)

Not approved by FDA. Sold for research use only in most jurisdictions.